Pembrolizumab,Lenvatinib,Regorafenib,trifluridine,Tipiracil
Merck,Eisai,Bayer,Taiho pharma,Pfizer
['trifluridine,tipiracil', 'ts,perio,1', 'colorectal', 'trifluridine', 'regorafenib', 'rectal', 'pembro', 'lenva', 'ts,perio,i']
a leap too far: pembro/lenva doesn t beat standard of care trifluridine/tipiracil or regorafenib in 3rd-line met #colorectalcancer in os (leap-017) despite small but encouraging orr and pfs benefits - but maybe in patients without liver mets??? #wcgic2023 
GI Medical Oncologist, Associate Professor of Medicine @Georgetown @RueschCenter @LombardiCancer, Ex-@SidwellFriends @Penn @KeckMedUSC keyboardist @BasementRiot